FCM/FACS (Flow Cytometry)
(Untransfected HEK-293T cells (green line) and transfected Human CLDN9 HEK-293T stable cells (red line) were stained with anti-CLDN6/9 antibody (AAA279305) (2ug/1*106cells), washed and then followed by APC-conjugated anti-Mouse IgG Fc antibody and analyzed with flow cytometry.)
CLDN6/9 recombinant antibody
CLDN6/9 Recombinant Monoclonal Antibody
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
FCM/FACS (Flow Cytometry)
(Untransfected HEK-293T cells (green line) and transfected Human CLDN9 HEK-293T stable cells (red line) were stained with anti-CLDN6/9 antibody (AAA279305) (2ug/1*106cells), washed and then followed by APC-conjugated anti-Mouse IgG Fc antibody and analyzed with flow cytometry.)
FCM/FACS (Flow Cytometry)
(Untransfected HEK-293T cells (green line) and transfected Human CLDN9 HEK-293T stable cells (red line) were stained with anti-CLDN6/9 antibody (AAA279305) (2ug/1*106cells), washed and then followed by APC-conjugated anti-Mouse IgG Fc antibody and analyzed with flow cytometry.)
FCM/FACS (Flow Cytometry)
(Untransfected CHO-K1*106cells), washed and then followed by APC-conjugated anti-Mouse IgG Fc antibody and analyzed with flow cytometry.)
FCM/FACS (Flow Cytometry)
(Untransfected CHO-K1*106cells), washed and then followed by APC-conjugated anti-Mouse IgG Fc antibody and analyzed with flow cytometry.)
FCM/FACS (Flow Cytometry)
(Untransfected HEK-293T cells (green line) and transfected Human CLDN6 HEK-293T stable cells (red line) were stained with anti-CLDN6/9 antibody(AAA279305) (2ug/1*106cells), washed and then followed by APC-conjugated anti-Mouse IgG Fc antibody and analyzed with flow cytometry.)
FCM/FACS (Flow Cytometry)
(Untransfected HEK-293T cells (green line) and transfected Human CLDN6 HEK-293T stable cells (red line) were stained with anti-CLDN6/9 antibody(AAA279305) (2ug/1*106cells), washed and then followed by APC-conjugated anti-Mouse IgG Fc antibody and analyzed with flow cytometry.)
ELISA
(The Binding Activity of Human CLDN6 with Anti-CLDN6-9 recombinant antibodyActivity: Measured by its binding ability in a functional ELISA. Immobilized Human CLDN6-9 (CSB-MP005511HU) at 10 ug/mL can bind Anti-CLDN6-9 recombinant antibody. The EC50 is 2.876-3.657 ng/mL. The VLPs (CSB-MP3838) is negative control.)
ELISA
(The Binding Activity of Human CLDN6 with Anti-CLDN6-9 recombinant antibodyActivity: Measured by its binding ability in a functional ELISA. Immobilized Human CLDN6-9 (CSB-MP005511HU) at 10 ug/mL can bind Anti-CLDN6-9 recombinant antibody. The EC50 is 2.876-3.657 ng/mL. The VLPs (CSB-MP3838) is negative control.)
ELISA
(The Binding Activity of Human CLDN6 with Anti-CLDN6-9 recombinant antibodyActivity: Measured by its binding ability in a functional ELISA. Immobilized Human CLDN6 (CSB-MP005508HU(A4)) at 10 ug/mL can bind Anti-CLDN6-9 recombinant antibody. The EC50 is 1.189-1.618 ng/mL. The VLPs (CSB-MP3838) is negative control.)
ELISA
(The Binding Activity of Human CLDN6 with Anti-CLDN6-9 recombinant antibodyActivity: Measured by its binding ability in a functional ELISA. Immobilized Human CLDN6 (CSB-MP005508HU(A4)) at 10 ug/mL can bind Anti-CLDN6-9 recombinant antibody. The EC50 is 1.189-1.618 ng/mL. The VLPs (CSB-MP3838) is negative control.)
NCBI and Uniprot Product Information
Similar Products
Product Notes
The CLDN6/9 cldn6 (Catalog #AAA279305) is a Recombinant Antibody produced from HEK293F Cell and is intended for research purposes only. The product is available for immediate purchase. The CLDN6/9 Recombinant Monoclonal Antibody reacts with Human and may cross-react with other species as described in the data sheet. AAA Biotech's CLDN6/9 can be used in a range of immunoassay formats including, but not limited to, FCM/FACS (Flow Cytometry), ELISA. Researchers should empirically determine the suitability of the CLDN6/9 cldn6 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "CLDN6/9, Monoclonal Recombinant Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.